Medicine without Meds
Johns Hopkins University Press (Verlag)
978-1-4214-4703-2 (ISBN)
Traditional health care has a new ally. Some patients with sleep disorders, back pain, and diabetes are now being prescribed app-based treatment instead of drugs. Algorithms are helping cancer patients manage their symptoms, and video games are improving the attention span of children diagnosed with ADHD. A new class of medicine called digital therapeutics (DTx) is gaining traction and transforming the way patients engage with the health care system. In Medicine without Meds, Dean Ho, Yoann Sapanel, and Agata Blasiak explore the exciting potential for these digital therapies to transform patient care.
Ho, Sapanel, and Blasiak share their insights on how these therapies can deliver value beyond the technology, address the challenges of implementation in existing health care models, and revolutionize care delivery. These clinicians, researchers, engineers, patients, start-up founders, and corporate executives are at the forefront of designing and building tomorrow's DTx. They explain what DTx represents, how it differs from other digital health solutions, and how these tools can be conceptualized, created, and brought to market. Throughout, case studies from leading DTx organization such as Akili Interactive, MedRhythms, and Welldoc illuminate best practices in product development, issues to consider, and pitfalls to avoid. These essays, along with a foreword by D. A. Wallach and Dr. Eddie Martucci's outlook on the future of DTx, present the exciting potential for DTx to reimagine health care for all.
Dean Ho (SINGAPORE) is the Provost's Chair Professor, the Director of the Institute for Digital Medicine and the N.1 Institute for Health, and the Head of the Department of Biomedical Engineering at the National University of Singapore. Yoann Sapanel (SINGAPORE) is the Head of Health Innovation at the Institute for Digital Medicine at the National University of Singapore. Agata Blasiak (SINGAPORE) is the Head of Digital Health Innovation at the Institute for Digital Medicine and the N.1 Institute for Health at the National University of Singapore.
Foreword
D. A. Wallach
Preface
Introduction. The Context
Part I. What Are Digital Therapeutics?
Chapter 1. Digital Health Solutions versus Digital Therapeutics
Part II. The Right Tool for the Right Problem
Chapter 2. Addressing Unmet Stakeholder Needs
Chapter 3. Addressing Unmet Clinical Needs
Chapter 4. Ensuring Business Viability Early
Chapter 5. Test, Learn, and Pivot
Part III. From Pilot to Production
Chapter 6. Data Sourcing and Management
Chapter 7. Clinical Validation: Unique Challenges and Novel Approaches
Chapter 8. Factors That Influence the Implementation of New Technologies
Chapter 9. Recommendations for DTx Implementation
Chapter 10. Supporting Adoption of DTx
Part IV. Paths to Commercialization
Chapter 11. Channel Partnerships: The Ultimate Commercialization Strategy
Chapter 12. The Price Is Right: Value in the Eye of the Beholder
Conclusion. The Future of DTx
With Dr. Eddie Martucci
Acknowledgments
Appendix A. AI and Its Potential Use in DTx: A Brief Overview of Frequently Asked Questions
Appendix B. How to Translate Evidence-Based Theories to the Design of Digitally Delivered Mental Health Interventions
Bibliography
Index
| Erscheinungsdatum | 21.10.2023 |
|---|---|
| Zusatzinfo | 12 Line drawings, black and white; 5 Halftones, black and white |
| Verlagsort | Baltimore, MD |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Gewicht | 658 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Medizinethik |
| Studium ► Querschnittsbereiche ► Geschichte / Ethik der Medizin | |
| Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung | |
| Recht / Steuern ► EU / Internationales Recht | |
| Recht / Steuern ► Privatrecht / Bürgerliches Recht ► Medizinrecht | |
| ISBN-10 | 1-4214-4703-7 / 1421447037 |
| ISBN-13 | 978-1-4214-4703-2 / 9781421447032 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
